Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-973
Closed -$95K 303
2025
Q3
$95K Sell
973
-10,396
-91% -$837K 0.02% 507
2025
Q2
$792K Buy
11,369
+3,311
+41% +$189K 0.17% 192
2025
Q1
$400K Buy
+8,058
New +$509K 0.2% 173

Other funds holding ACLS

iSAM Funds (UK)'s ACLS Position: Q4 2025 in Review

iSAM Funds (UK) sold out of Axcelis (ACLS) in Q4 2025, closing a stake of 973 shares — an estimated $95K sold.

iSAM Funds (UK) first reported a position in ACLS in Q1 2025 and held it in 3 quarters. The position peaked at $792K in Q2 2025. 370 funds tracked by Wall St. Rank hold ACLS as of Q4 2025.

  • iSAM Funds (UK) reported no remaining Axcelis position as of Q4 2025 after selling out during the quarter.
  • iSAM Funds (UK) sold 973 Axcelis shares in Q4 2025, an estimated $95K.
  • iSAM Funds (UK) first reported a position in Axcelis in Q1 2025 and held it in 3 quarters.
  • iSAM Funds (UK)'s Axcelis position peaked at $792K in Q2 2025.
  • 370 funds tracked by Wall St. Rank held Axcelis as of Q4 2025.

Based on iSAM Funds (UK)'s 13F filing for Q4 2025, filed 17 Feb 2026.